Vaxcyte, Inc.
PCVX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,987 | $6,101 | $3,111 | $1,235 |
| - Cash | $388 | $397 | $835 | $69 |
| + Debt | $71 | $29 | $18 | $17 |
| Enterprise Value | $9,670 | $5,733 | $2,294 | $1,183 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$448 | -$392 | -$214 | -$97 |
| % Margin | – | – | – | – |
| Net Income | -$464 | -$402 | -$223 | -$100 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.8 | -4.14 | -3.44 | -1.93 |
| % Growth | 8.2% | -20.3% | -78.2% | – |
| Operating Cash Flow | -$453 | -$297 | -$171 | -$121 |
| Capital Expenditures | -$22 | -$68 | -$6 | -$7 |
| Free Cash Flow | -$475 | -$365 | -$176 | -$128 |